Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

SWHFX vs GGHCX overlap: 51% of top holdings shared

Bottom line

How much do SWHFX and GGHCX overlap?

51% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 43.7% of SWHFX's assets and 39.3% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

SWHFXGGHCX
Weight overlap (top 25)51%
Shared holdings8
Weight in shared holdings43.7%39.3%
Total positions8082
Expense ratio0.8%1.07%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings SWHFX and GGHCX have in common

Holding% of SWHFX% of GGHCXOverlap
Eli Lilly & Co13.92%10.59%10.59%
Johnson & Johnson6.94%6.76%6.76%
AbbVie Inc5.81%4.03%4.03%
Merck & Co Inc4.98%4.59%4.59%
UnitedHealth Group Inc4.74%6.17%4.74%
Gilead Sciences Inc3.24%3.63%3.24%
Thermo Fisher Scientific Inc2.16%1.55%1.55%
Vertex Pharmaceuticals Inc1.89%2.01%1.89%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in SWHFX

  1. Novartis AG — 2.92%
  2. Amgen Inc — 2.58%
  3. Bristol-Myers Squibb Co — 2.44%
  4. Medtronic PLC — 2.29%
  5. Roche Holding AG — 2.29%
  6. Stryker Corp — 2.11%
  7. Gsk Plc — 1.73%
  8. Boston Scientific Corp — 1.60%
  9. Abbott Laboratories — 1.60%
  10. Cigna Group/The — 1.51%
  11. Danaher Corp — 1.47%
  12. Elevance Health Inc — 1.45%
  13. Incyte Corp — 1.37%
  14. Ipsen SA — 1.34%
  15. Sanofi SA — 1.31%

Only in GGHCX

  1. Invesco Private Prime Fund — 4.67%
  2. argenx SE — 3.24%
  3. CVS Health Corp. — 2.52%
  4. Welltower Inc. — 2.34%
  5. BrightSpring Health Services, Inc. — 2.20%
  6. Royalty Pharma PLC — 2.13%
  7. Cardinal Health, Inc. — 2.10%
  8. Guardant Health, Inc. — 2.04%
  9. Invesco Private Government Fund — 1.80%
  10. Axsome Therapeutics, Inc. — 1.58%
  11. Edwards Lifesciences Corp. — 1.56%
  12. Invesco Treasury Portfolio — 1.56%
  13. BridgeBio Pharma, Inc. — 1.43%
  14. Waters Corp. — 1.41%
  15. IQVIA Holdings Inc. — 1.32%

Asset mix

Asset typeSWHFXGGHCX
Stocks99.0%97.5%
Cash & short-term funds—8.8%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountrySWHFXGGHCX
US78.6%93.5%
CH5.2%2.7%
IE4.5%0.6%
NL0.7%3.4%
GB3.4%3.1%
FR2.6%—
JP2.3%—
BE—1.2%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do SWHFX and GGHCX overlap?
About 51% by weight. 8 securities appear in both funds' top 25 holdings; they make up 43.7% of SWHFX's assets and 39.3% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do SWHFX and GGHCX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, UnitedHealth Group Inc, Merck & Co Inc, AbbVie Inc.
Should I own both SWHFX and GGHCX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, SWHFX or GGHCX?
GGHCX is broader, with 82 positions versus 80 for SWHFX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.